Phase II, randomised, double‐blind, placebo‐controlled trial of methylphenidate for reduction of fatigue levels in patients with prostate cancer receiving LHRH‐agonist therapy

Publisher: John Wiley & Sons Inc

E-ISSN: 1464-410x|116|5|744-752

ISSN: 1464-4096

Source: BJU INTERNATIONAL, Vol.116, Iss.5, 2015-11, pp. : 744-752

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content